TITLE

SYMPLICITY HTN-4 may extend population for renal denervation

AUTHOR(S)
PEDERSEN, AMANDA
PUB. DATE
November 2013
SOURCE
Medical Device Daily;11/8/2013, Vol. 17 Issue 217, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article discusses the SYMPLICITY HTN-4, Medtronic's second randomized, controlled renal denervation clinical trial in the U.S. and the first randomized trial in the country to investigate renal denervation for the treatment of moderate uncontrolled hypertension. An overview of SYMPLICITY HTN-4 is presented.
ACCESSION #
91891038

 

Related Articles

  • FDA panel recommends premarket approval application for AcrySof IQ ReSTOR multifocal toric IOL.  // Ocular Surgery News;12/10/2014, Vol. 32 Issue 23, p31 

    The article reports that the Ophthalmic Devices Panel of the Medical Devices Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to recommend premarket approval application for AcrySof IQ ReSTOR +3.0 multifocal toric intraocular lens (IOL) of medical company Alcon.

  • Tech innovation. HART, STUART; ARMSTRONG, MARK // Contemporary OB/GYN;Oct2015, Vol. 60 Issue 10, p16 

    The article offers an overview of the process of commercializing a medical device innovation. Topics discussed include evaluation, requirements of the U.S. Food and Drug for approval based on safety land effectiveness land conformance to Good Manufacturing Practices. It also discusses...

  • Med-Tech Notes.  // Medical Device Daily;2/12/2013, Vol. 17 Issue 29, p8 

    The article offers news briefs related to medical technology in the U.S. The Food and Drug Administration (FDA) has granted Lantheus Medical Imaging an approval for a Supplemental New Drug Application (sNDA) which allows Jubilant HollisterStier to be a manufacturing site. The medical device...

  • Medtronic gets FDA approval for Lead Integrity Alert software. FORD, OMAR // Medical Device Daily;11/11/2013, Vol. 17 Issue 218, p1 

    The article offers information on the Lead Integrity Alert software from Medtronic Inc. which received an approval from the Food and Drug Administration (FDA) to report performance issues on St. Jude's Durata and Boston Scientific's Endotak defibrillator leads.

  • Hand-held VivaScope brings to mind Star Trek's tricorder. PEDERSEN, AMANDA // Medical Device Daily;11/12/2013, Vol. 17 Issue 219, p1 

    The article reports on the launch of the noninvasive device VivaScope by medical device company Caliber Imaging & Diagnostics (Caliber I.D.) designed to take detailed images and allows real-time detection and diagnosis of skin diseases including skin cancer. Due to its noninvasiveness, risks of...

  • Product Briefs.  // Medical Device Daily;11/21/2013, Vol. 17 Issue 226, p10 

    The article offers information on several medical device products including Boston Scientific's Direxion Torqueable Microcatheter, Covidien's Vital Sync virtual patient monitoring platform, and Illumina's MiSeqDx system, a DNA sequencing analyzer.

  • FDA clears Electromed's next generation SmartVest system. Pedersen, Amanda // Medical Device Daily;12/31/2013, Vol. 17 Issue 251, p1 

    The article offers information on the SQL model of SmartVest Airway Clearance System, a precursor device to promote airway clearance which been cleared to market by the U.S. Food and Drug Administration (FDA), from Electromed Inc.

  • FDA clears SinuSys' in-office sinus dilation system, Vent-Os. Pedersen, Amanda // Medical Device Daily;1/7/2014, Vol. 18 Issue 4, p1 

    The article reports that the U.S. Food & Drug Administration (FDA) has cleared Vent-Os sinus dilation system developed by SinuSys. Vent-Os sinus dilation system has been designed to resolve sinusitis symptoms and is aimed at maximizing tolerability of patient under local anesthesia. SinuSys is...

  • FDA Plans to Tighten Regulations Concerning Defibrillators. Lincoln, John E. // Journal of Validation Technology;Jun2013, Vol. 19 Issue 2, p1 

    The article offers the author's view on the proposals of the U.S. Food and Drug Administration (FDA) which aims at helping manufacturers improved quality and reliability of automated external defibrillators (AEDS). He states that if the proposals will be finalized, it will require manufacturers...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics